{"id":"W2053643895","doi":"10.1097/coc.0000000000000099","title":"Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Aegera Therapeutics (Canada)","funders":"Chinese University of Hong Kong; University of Hong Kong","keywords":"Sorafenib; Medicine; Hepatocellular carcinoma; Clinical endpoint; Internal medicine; Adverse effect; Response Evaluation Criteria in Solid Tumors; Oncology; Combination therapy; Randomized controlled trial; Surgery; Phases of clinical research; Gastroenterology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001636497,0.0001344126,0.00121853,0.0001058928,0.00002763062,0.000002278829,0.0001665182,0.0001095434,0.000002918121],"category_scores_gemma":[0.0004388568,0.00007777007,0.0001633075,0.0002441817,0.0004259043,0.000008676068,0.00005958733,0.0002270339,7.97245e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002118597,"about_ca_system_score_gemma":0.0001807598,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005050306,"about_ca_topic_score_gemma":0.00005892374,"domain_scores_codex":[0.996725,0.001251278,0.001428144,0.0001994273,0.0002558485,0.0001402981],"domain_scores_gemma":[0.9968035,0.0002645187,0.002273676,0.0002289749,0.000363543,0.00006576007],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3131574,0.01769925,0.4952557,0.00002381272,0.0002859176,0.000007622752,0.0006709945,0.0009528702,0.04008374,0.00005053541,0.00001080479,0.1318013],"study_design_scores_gemma":[0.6553365,0.1459934,0.1709658,0.0001206119,0.0002551582,0.000007064014,0.000754981,0.001009089,0.02505492,0.00007659115,0.0002023236,0.0002236422],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984935,0.00002636434,0.0005192735,0.0001269249,0.0001663462,0.0006421611,0.000001694664,9.98077e-7,0.00002276965],"genre_scores_gemma":[0.9989313,0.00004224754,0.0008825356,0.00005610349,0.00005005581,0.000007876622,0.000006782146,0.00001388919,0.00000924479],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3421791,"threshold_uncertainty_score":0.3171372,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01424811366629331,"score_gpt":0.3143347235867825,"score_spread":0.3000866099204892,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}